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Background: mAb Elec410 inhibits acetylcholinesterase by binding at the active site gorge entrance.
Results: Biochemical and structural characterization of Fab410-bound acetylcholinesterase reveals residual catalytic activity,
coexisting open/closed states of a back door channel, and a semi-occluded gorge entrance.
Conclusion: Bound antibody restricts substrate access through the gorge and may modulate back door opening.
Significance: This unique molecular template with high frequency back door opening refines our understanding of acetylcho-
linesterase catalysis.
The acetylcholinesterase found in the venom of Bungarus fas-
ciatus (BfAChE) is produced as a soluble, non-amphiphilic
monomer with a canonical catalytic domain but a distinct C
terminus compared with the other vertebrate enzymes. More-
over, the peripheral anionic site of BfAChE, a surface site
located at the active site gorge entrance, bears two substitutions
altering sensitivity to cationic inhibitors. Antibody Elec410,
generated against Electrophorus electricus acetylcholinesterase
(EeAChE), inhibits EeAChE and BfAChE by binding to their
peripheral sites. However, both complexes retain significant
residual catalytic activity, suggesting incomplete gorge occlu-
sion by bound antibody and/or high frequency back door open-
ing. To explore a novel acetylcholinesterase species, ascertain
the molecular bases of inhibition by Elec410, and document the
determinants and mechanisms for back door opening, we solved
a 2.7-Å resolution crystal structure of natural BfAChE in com-
plex with antibody fragment Fab410. Crystalline BfAChE forms
the canonical dimer found in all acetylcholinesterase structures.
Equally represented open and closed states of a back door chan-
nel, associated with alternate positions of a tyrosine phenol ring
at the active site base, coexist in each subunit. At the BfAChE
molecular surface, Fab410 is seated on the long -loop between
two N-glycan chains and partially occludes the gorge entrance, a
position that fully reflects the available mutagenesis and bio-
chemical data. Experimentally based flexible molecular docking
supports a similar Fab410 binding mode onto the EeAChE anti-
gen. These data document the molecular and dynamic peculiar-
ities of BfAChE with high frequency back door opening, and the
mode of action of Elec410 as one of the largest peptidic inhibi-
tors targeting the acetylcholinesterase peripheral site.
Acetylcholinesterase (AChE4; EC 3.1.1.7) rapidly terminates
cholinergic neurotransmission by catalyzing hydrolysis of the
neurotransmitter acetylcholine at neuronal and neuromuscular
synapses (1–3). The active site of AChE, which contains the
Glu/His/Ser catalytic triad and binds competitive reversible or
irreversible inhibitors, is positioned at the center of the subunit
at the bottom of a long and narrow gorge (4), a geometry not
reflecting the high rate of catalytic activity (turnover number up
to 104 s1) of the enzyme (5). At the enzyme surface and
entrance of the active site gorge, the peripheral anionic site
(PAS) encompasses overlapping binding loci for a range of pos-
itively charged, reversible modulators of catalysis (6 –9). Inhib-
itor binding at the PAS appears to limit the catalytic efficiency
by combined steric and electrostatic blockade of ligand traffick-
ing through the gorge and by altering the active site conforma-
tion (10 –13). The surface topography and conformational flex-
ibility of this site have been characterized in detail; however, the
mechanisms involved in its allosteric functioning remain
unclear (14 –20).
The so-called “back door region,” which is also at the enzyme
surface but remote from the gorge entrance, has been another
matter of discussion. Indeed, transient enlargement or opening
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of a back door would permit fractional substrate or product
trafficking into or out of the enzyme, thereby contributing to
the high catalytic activity of the enzyme (21, 22) and to the
residual activity of its complex with the large snake toxin fasci-
culin 2 (Fas2) bound at the PAS (14, 23). Shutter-like motion of
the aromatic side chain of either residue Trp84 or residue Tyr442
(Torpedo californica AChE (TcAChE) numbering), whose aro-
matic rings make thin walls in the back door region between the
active site pocket and the outside solvent, were first visualized
by molecular dynamics simulations (21, 22, 24). Subsequent
evidence for an open back door channel was found upon crys-
tallographic analysis of Drosophila AChE (DmAChE) where
genuine Ile and Asp substitutions to Met83 and Tyr442, respec-
tively, were found to weaken the interaction network in this
region (25), and in a combined crystallography and molecular
dynamics simulation study of TcAChE in complex with PAS-
bound aflatoxin where channel opening was attributed to con-
certed motions of Tyr442 and Trp84 (26). Complementary crys-
tal structures of mouse AChE (mAChE), an inactive mAChE
mutant, and TcAChE bound with a range of substrates, sub-
strate analogues, and reaction products led us and others to
picture successive positions and orientations for an incoming
substrate, first bound at the PAS and then proceeding within
the gorge toward the active site; the conformations of the pre-
sumed transition state for acylation and the acyl-enzyme inter-
mediate; the positions and orientations of the dissociating and
egressing products (8, 9); and unexpected substrate binding
sites at the enzyme surface in the back door region (8). Hence,
transient back door opening, likely to be associated with sub-
stantial conformational fluctuation in the protein core, is
clearly linked to the dynamic properties or breathing motions
underlying the catalytic mechanism of AChE.
The venoms of some Elapidae snakes are abundant sources of
non-synaptic (non-cholinergic) AChE of an unknown physio-
logical role because it is non-toxic by itself and does not
enhance the toxicity of the pharmacologically active venom
components (27–29). However, it could be a vestige of the pan-
creatic origin of the venom gland (30). These snake venom
AChEs are inhibited by small, organic PAS ligands such as pro-
pidium, albeit at a lower affinity compared with the other spe-
cies found in neuronal or neuromuscular tissues, but they differ
widely in their sensitivity to larger, peptidic PAS ligands such as
Fas2 or mAb Elec410 (see below) (27, 31, 32). For example, the
venom enzymes from Bungarus fasciatus (BfAChE) and Ophio-
phagus hannah are inhibited by Fas2 and Elec410, whereas
those from Naja haje and Hemachatus haemachatus are not
(27). BfAChE is a true AChE (as is its more recently studied
Bungarus sindanus ortholog (Ref. 33 and references therein)),
and it displays all the structural and catalytic characteristics of
AChEs from cholinergic tissues, including the presence of a
large permanent dipole moment (Refs. 34 – 40 and for reviews,
see Refs. 41 and 42). However, unlike the AChEs from cholin-
ergic tissues that bear C-terminal tailed (“T”) or hydrophobic
(“H”) peptides and can form oligomers (for a review, see Ref.
43), BfAChE is expressed in the venom and in mammalian cell
models as a hydrophilic monomer characterized by a short
C-terminal soluble (“S”) peptide (38). Compared with Torpedo
and mammalian AChEs, BfAChE also presents two non-con-
servative substitutions at the PAS, corresponding to replace-
ment of Tyr70 (TcAChE numbering) by a Met and of the acidic
residue at position 285 by a Lys, on opposite sides of the gorge
rim. Comparative analysis of wild-type BfAChE and its
“reverse” M70Y and K285D mutants ascertained both the
responsibility of these two substitutions for the low sensitiv-
ity of BfAChE to various PAS inhibitors, and their absence of
effect on its catalytic turnover rate and competitive inhibi-
tion by active site ligands (38).
Elec410, one of the three inhibitory mAbs raised against nat-
ural Electrophorus electricus AChE (EeAChE), was initially
reported to inhibit BfAChE with an apparent Ki or IC50 value
“in the nanomolar range” versus the Kd value of 0.04 nM
reported for the EeAChE antigen (27, 31). This property and
availability of the two protein sequences (38, 44) were instru-
mental in delineating the binding site of Elec410 (and those of
its Elec403 and Elec408 congeners) at the EeAChE surface using
complementary biochemical and mutagenesis approaches (45).
In particular, these studies identified distinct but overlapping
loci at the PAS surface as the binding sites for Elec410 and
Elec403 and the back door region as the binding site for
Elec408. In a preliminary structure-function relationship study
of the Fab fragments of these mAbs (46), comparison of
BfAChE and EeAChE inhibition by Fab410 pointed to a greater
residual activity for the BfAChE complex, suggesting slight var-
iability in the Fab410 position or strength of interaction at the
two gorge entrances (as would be expected from the sequence
and affinity differences) and/or in the opening width or fre-
quency of the two back doors. More recently, a comprehensive
analysis of the molecular determinants dictating the binding
specificity and mode of action of these three mAbs led us to
document their nucleotidic and peptidic sequences, the bio-
chemical features and functional properties toward EeAChE of
their Fab domains, a crystal structure of Fab408 and homology
models of Fab403 and Fab410, and a data-driven docking model
of an Fab403-EeAChE complex (32). The combining site of
Fab410 was pictured as a 1000-Å2 surface area mostly popu-
lated by cationic side chains with a highly electropositive CDR
H2 and a protruding CDR H3 well positioned for interaction
with the PAS surface. In turn, comparison of the protein
sequences in the two PAS regions pointed to several substitu-
tions, of which some generate or eliminate consensus N-glyco-
sylation sequences, as likely candidates for dictating slightly
distinct poses of bound Fab410. Therefore, BfAChE and Fab410
respectively appeared as a new AChE model and a new, non-
competitive, peptidic ligand probe suitable for further explora-
tion of the mechanisms for regulation of catalysis triggered by
the PAS and the back door region.
In this context, we solved a crystal structure of natural, gly-
cosylated BfAChE in complex with Fab410 and generated an
experimentally based homology model of the Fab410-EeAChE
complex. This comprehensive study documents the molecular
and dynamic peculiarities of BfAChE with high back door
opening frequency, along with the mode of action of Elec/
Fab410 as one of the largest peptidic inhibitors targeting the
PAS of an AChE.
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Materials—Dried B. fasciatus venom was a gift from Dr. Cas-
sian Bon (Institut Pasteur, Paris, France). The crude ascitic fluid
for Elec410, the sequence of Fab410 prior to publication, and a
reference sample of purified BfAChE, respectively, were pro-
vided by Dr. Jacques Grassi, Dr. Didier Boquet, and Dr. Chris-
tophe Créminon (Commissariat à l’Energie Atomique Saclay,
Gif-sur-Yvette, France). The prepacked Superdex-200 HR-10/30
and HL-26/60 columns and protein G- and protein A-Sepharose
HiTrap units (1 ml) and the calibration markers for gel filtration
were from GE Healthcare. PEG 8000 was from Hampton
Research, and sodium citrate from Fluka. The molecular weight
standards for SDS-PAGE and all others biochemical reagents
were from Sigma-Aldrich.
Protein Purification and Preparation—mAb Elec410 was
produced as an IgG1, from murine hybridoma (31). Isolation
of Elec410 from the ascitic fluid and preparation and purifica-
tion of Fab410 and its physical characterization by MALDI-
TOF MS and various electrophoretic means were described
previously (32). Purified Fab410 was dialyzed against 50 mM
Tris, pH 7.5, 50 mM NaCl, 0.01% (w/v) NaN3 and concentrated
to 5 mg/ml.
BfAChE was isolated from the venom by affinity chromatog-
raphy on immobilized m-carboxyphenyldimethylethyl using
elution by 20 mM decamethonium (38, 47). It was further puri-
fied by gel filtration on Superdex-200 in 100 mM sodium phos-
phate, pH 7.4, 100 mM NaCl, 0.01% (w/v) NaN3. When eluting
at 0.25 mg/ml from the gel filtration column, BfAChE
behaved as a monomer. Injection at very high concentration to
explore elution as a dimer and compensate for the 10-fold
dilution occurring on the column was not attempted. Purified
BfAChE was extensively dialyzed against 10 mM Hepes, pH 7.5,
50 mM NaCl, 0.01% (w/v) NaN3 and concentrated to 2.5 mg/ml.
Homogeneity was assessed by SDS- and native PAGE (see
below and Fig. 1).
The Fab410-BfAChE complex used for crystallogenesis was
formed with a slight molar excess of Fab410 over the enzyme
and incubated for 2 h at room temperature and then overnight
at 4 °C. Unbound Fab410 was removed by gel filtration on
Superdex-200 in 10 mM Hepes, pH 7.5, 50 mM NaCl, 0.01%
(w/v) NaN3. The complex was concentrated to 10 mg/ml, fil-
trated, and stored on ice.
Biochemical and Functional Analyses—SDS- and native
PAGE used a PhastSystem apparatus (GE Healthcare); homog-
enous 12.5 and 7.5% PhastGels, respectively; migration toward
the anode; and silver or Coomassie Blue staining. SDS-PAGE
samples were boiled for 5 min in the presence of 2.5% (w/v) SDS
with (reducing conditions) or without (non-reducing condi-
tions) 5% (v/v) -mercaptoethanol. Isoelectric focusing analysis
used the same apparatus and pI 4.0 – 6.5 PhastGels preloaded
with ampholytes. Native PAGE mobility shift assays used com-
plexes formed in solution with a 0.75–1.2 molar excess of
Fab410 over BfAChE (3-h incubation at room temperature).
AChE activities were recorded from duplicates for 5 min on a
UNICAM 8700 spectrophotometer (Thermo Optek) using
10 –25 pM EeAChE or BfAChE, 1.25 mM acetylthiocholine
iodide (10  Km), and 0.33 mM dithiobis(2-nitrobenzoic acid)
in 100 mM sodium phosphate, pH 8.0, 0.1 mg/ml BSA (  412
nm) (48). The control AChE samples and the IgG/ or Fab/AChE
mixtures were incubated overnight under mild agitation at
room temperature before recording their residual (fractional)
activity. Data analysis used GraphPad Prism 6, a sigmoidal
dose-response equation, and one-way analysis of variance. Data
are summarized in Table 1.
Crystallization—Crystallization was achieved manually at
20 °C by vapor diffusion using the Fab410-BfAChE complex at
10 mg/ml, 1-l hanging drops, and a protein-to-well solution
ratio of 1:1. Fine plate crystals grew spontaneously within 10
days with 12.5% (v/v) PEG 8000, 200 mM sodium citrate, pH 5.0
as the well solution. Thicker plates were obtained by seeding in
sitting drops with 7% (v/v) PEG 8000, 200 mM sodium citrate,
pH 5.0. Crystals were flash cooled in a nitrogen gas stream after
successive short soaks in the well solution supplemented with
7.5, 15, and 25% (v/v) ethylene glycol, and stored in liquid nitro-
gen. Diffraction data were collected at 100 K at the European
Synchrotron Radiation Facility (Grenoble, France), processed
with MOSFLM (49), and scaled and merged with SCALA (50).
Solution and Refinement of the Fab410-BfAChE Complex—
Initial phases were obtained by molecular replacement with the
AMoRe program package (51) using as search models the struc-
tures of apo-mAChE (Protein Data Bank (PDB) code 1J06 (18))
and antibody HFE7A (PDB code 1IQW (52)). Various normal
mode-perturbed models of the Fab template harboring a range
of elbow angles were generated using the ElNemo server (53).
Among them, five models were selected based on their lowest
correlation coefficient and R-factor values during molecular
replacement searches and subsequently used as a Phaser
ensemble (54). This procedure yielded a final solution with a
log-likelihood gain score of 2455 in the 40 –2.75-Å resolution
range. The model was improved by manual adjustment with the
graphics program Coot (55) and refined with REFMAC (56)
and autoBUSTER (57), including non-crystallographic symme-
try restraints and translation/libration/screw refinement with
each AChE subunit and Fab410 variable and constant domain
defining a translation/libration/screw group. Data collection
and refinement statistics are summarized in Table 2.
The final structure of the Fab410-BfAChE complex com-
prises 528 residues (Gly4–Thr535; Fig. 2A) for each subunit in
the crystalline BfAChE dimer (0.3 Å for 528 C atoms); 212 and
225 residues for each of the two Fab410 light (L) and heavy (H)
chains, respectively; and 188 water molecules. The BfAChE
gorge is free of any component from the purification, crystalli-
zation, or flash cooling solutions. The Fab410 molecule shows
an elbow angle of 142° between the pseudodyad axes relating
the variable (V) and constant (C) domains of the H and L chains.
The Fab410 CDR boundaries were defined according to the
IMGT standards as described (32). However, to avoid virtual
gaps in the structure coordinates and inconsistencies related to
definition of -strands, the consecutive numbering of residues
and Greek letter labeling of -strands and -helices will be used
herein (Fig. 2B). CDRs L1, L2, and H1 clearly belong to the
canonical structural class 1, whereas CDR L3 is only similar to
class 1; CDR H2, which is the most exposed to solvent, belongs
to class 4; and CDR H3, which encompasses 14 residues, is a
non-canonical CDR. High temperature factors and weak elec-
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tron densities are associated with the surface loop region
Asp487–Gly490 and segments Gly4–Val57, Cys254–Cys265,
Lys315–Gln318, Ala412–Asn415, and Pro482–Ala486 in BfAChE
and with the surface loop region Ser140–Asn145 in the H chain
of Fab410 (Fig. 2). Stereochemistry of the structure was ana-
lyzed with MolProbity (58); only Fab410 L chain residue Ala51
was found in the disallowed regions of the Ramachandran plot.
Structural Analysis and Comparisons—Electrostatic surface
potentials of BfAChE and Fab410 were calculated using APBS
(59) with the PyMOL APBS tools. The molecular surface area
buried to a 1.4-Å-radius probe at the Fab410-BfAChE complex
interface was calculated using PISA (60). Tunnels and channels
in AChE were computed with CAVER 3.0 (61). Structural
superimposition, based on the respective AChE subunits, of the
Fab410-BfAChE complex with the Fas2-mAChE complex
(PDB code 1KU6 (14); root mean square deviation value, 0.83 Å
for 516 C atoms), propidium-mAChE complex (PDB code
1N5R (18); 0.82 Å for 520 C atoms), acetylcholine/acetylthio-
choline-mAChE complexes (PDB codes 2HA4/2HA5 (8); 0.83/
0.79 Å for 521/518 C atoms), decamethonium-TcAChE com-
plex (PDB code 1ACL (62); 0.86 Å for 525 C atoms),
BW284C51-TcAChE complex (PDB code 1E3Q (63); 0.89 Å for
527 C atoms) and unliganded DmAChE (PDB code 1DX4
(64); 1.47 Å for 490 C atoms) and comparison of the bound
Fab410 structure with the theoretical model of unbound
Fab410 (Ref. 32; 1.8 and 2.6 Å for 208/203 C atoms for the L
and H chains, respectively) used Coot (55). Figs. 3– 6 were gen-
erated using PyMOL (65).
Theoretical Modeling of the Fab410-EeAChE Complex—A
previously designed model of the EeAChE subunit devoid of the
EeAChE-specific insert Ile418–Gln446 and C-terminal tailed
peptide Ala576–Leu610 (32) and the present, randomly oriented
Fab410 structure were used as templates. The model of the
Fab410-EeAChE complex was generated by flexible docking
using HADDOCK 2.1 (66) with default parameters and as pos-
sible interfacial active residues five residues of the EeAChE PAS
(Tyr71, Pro77, Trp281, Ser287, and Gly337) close to those residues
shown by mutagenesis to be important for Elec410 binding (45)
(see Fig. 2A) and five residues of the Fab410 CDRs (H chain
Arg52 and Tyr104 and L chain Ser30, Arg49, and His93 (see Fig.
2B) likely to be important for interaction with EeAChE (32).
Neighboring solvent-accessible residues (four for EeAChE and
five for Fab410) suitably positioned for being indirectly
involved in the binding were defined as passive residues. For
each run, the top 200 complexes generated after rigid body
energy minimization were subjected to flexible simulated
annealing in torsion angle space and to flexible water refine-
ment in Cartesian space, and the three energetically best mod-
els scored by HADDOCK were comparatively analyzed. Nine
ensembles of four energetically best models of a Fab410-
EeAChE complex were obtained of which the cluster with the
best HADDOCK scores closely resembles our experimental
structure of the Fab410-BfAChE complex.
As a control, a “reference” model of the Fab410-BfAChE
complex was generated using the same procedure and a ran-
domly oriented Fab410 molecule relative to the BfAChE sub-
unit, both extracted from the structure of the complex. Ambig-
uous interaction restraints similar to those for the Fab410-
EeAChE complex were defined from each partner using the
corresponding five active residues from the interfacial regions
of BfAChE (PAS region) and Fab410 (CDRs), respectively, and
four and five surrounding passive residues from each partner.
For each of the five ensembles of models obtained, the best
solution generated by HADDOCK matches our experimental
structure of the Fab410-BfAChE complex (root mean square
deviation value of 0.65 Å).
RESULTS AND DISCUSSION
Biochemical and Functional Characterization of the Fab410-
BfAChE Complex—Preparation, purification, and biochemical
analysis of Fab410, which is made of several charge isoforms,
and its functional characterization toward its EeAChE antigen
were described previously (32) (Table 1). Natural BfAChE was
purified from the B. fasciatus venom using standard affinity
chromatography and gel filtration procedures (38). Compre-
hensive electrophoretic analysis showed molecular homogene-
ity in mass but not in charge, consistent with variations in the
composition of the glycan chains linked to several (or all) of the
five consensus sites for N-glycosylation (Figs. 1, A and B, and
2A, black closed circles) (38, 41, 67). However, all Fab410 and
BfAChE isoforms have the capacity to form complexes as
assessed from the native PAGE patterns (Fig. 1C) and analytical
gel filtration profiles (data not shown) obtained upon analysis of
the complex stoichiometry.
Elec410 was reported to inhibit BfAChE “with an apparent Ki
in the nM range” (31). Curves for BfAChE inhibition by Elec410
and Fab410 spanning 2 orders of magnitude again ascertained
formation of equivalent complexes despite the charge hetero-
geneity of both partners, and validated the use of Fab410 for the
structural study (Fig. 1D). In turn, the slight difference in the
mean IC50 and residual activity values may denote the respec-
tive avidities of the IgG and Fab relatives, and/or experimental
variation since identical values were found for the EeAChE
antigen (Table 1). Compared with the EeAChE antigen, the
lower inhibition potency of Elec410 and Fab410 for BfAChE,
denoted by the 20 – 80-fold greater mean IC50 values (Table
1), reflects the amino acid sequence and possible N-glycosyla-
tion differences found in the PAS regions of the two AChE
species and likely to modulate the interaction network at the
two complex interfaces (see below). In turn, the 3– 6-fold
greater residual activity of bound BfAChE over EeAChE
recorded at saturating Elec410 and Fab410 concentrations may
TABLE 1
Parameters for inhibition of BfAChE and EeAChE by Elec410 (italics)
and Fab410 (plain)
BfAChEa,b EeAChE
IC50 Elec410 (nM) 10.9  0.9 0.47  0.18a,b
(8.1–13.7) (1.8–2.76)
IC50 Fab410 (nM) 33.4  5.0 0.42  0.03b,c
(11.8–54.9) (0.33–0.50)
Residual activity Elec410 (%) 28.1  0.9 4.75  0.55b,c
(25.2–31.0) (2.24–11.74)
Residual activity Fab410 (%) 13.7  1.9 4.50  0.62b,c
(5.4–22.1) (2.52–6.48)
a This study.
b Means  S.E. from three (Fab410/BfAChE), four (IgG410/BfAChE and Fab410/
EeAChE), and two (Elec410/EeAChE) independent experiments performed with
duplicates. The 95% confidence intervals are provided in parentheses ( p values
0.05).
c From Ref. 32 with modification.
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indicate slightly different mechanisms for substrate hydrolysis
or for enzyme inhibition by the bound antibody, associated
with architectural differences in the gorge paths or active cen-
ters of the two AChEs.
Overall View of the Fab410-BfAChE Complex—The 2.7-Å
resolution structure of the Fab410-BfAChE complex reveals the
same homodimeric assembly of AChE subunits as observed
previously in crystal structures of the recombinant mAChE
monomer and the natural covalent TcAChE dimer (Table 2 and
Fig. 3A). In fact, comparative analysis of the dimer interfaces in
BfAChE and mAChE, which share a buried surface area of
920 A2, points to subtle differences in the nature of the con-
tributing residues (e.g. BfAChE Gln374 that replaces mAChE
His381 at the center of the interface and BfAChE residues
Gln379, Pro500, Pro514, and His526 that replace mAChE residues
Leu386, Gln508, Arg522, and Arg534 at its periphery (Fig. 2A)) that
significantly alter the pattern of polar interactions found in the
mAChE dimer and may affect dimer stability. This observation
is consistent with the monomeric versus dimeric states of
BfAChE in low versus high concentration solutions (34, 37, 38)
(see “Experimental Procedures”) and, compared with mAChE,
its higher concentration dependence for dimer formation (data
not shown). The same features can be predicted for Naja naja
oxiana AChE (NnAChE), which was shown to behave as a
monomer at 0.2 mg/ml and a dimer at 2 mg/ml (68) and whose
single sequence difference with BfAChE in the dimerization
domain is a His substitution to Pro514.5
The BfAChE subunit shows the canonical /-hydrolase fold
of all cholinesterases (Figs. 3, A and B; 4A; and 5A), consistent
with their high sequence identity (Fig. 2A). Of the five potential
N-glycosylation sites predicted from the BfAChE sequence
(and conserved in NnAChE), two, located near the gorge rim at
Asn343 and Asn453, are occupied with a well ordered pentasac-
charide, whereas no electron density is associated with Asn457,
which is located near the Fab410 L chain and is occupied in
most AChEs (TcAChE Asn458; mAChE Asn464) (Figs. 2A, 3A,
4A, and 5A). Whether Asn457 is occupied with a highly disordered
glycan chain or whether glycosylation at Asn453 “compensates” for
the absence of glycosylation at Asn457 is unknown. The fourth and
fifth sites, located far from the gorge entrance at Asn258 and
Asn533, might be occupied as well because additional electron den-
sity is observed at each of these positions, although not sufficiently
resolved to permit the building of glycan molecules.
The BfAChE active site gorge, with key functional residues
lining its walls and the Ser200/Glu327/His447 catalytic triad at its
bottom, adopts the same shape as in other crystallized AChE
species. At the gorge entrance, the PAS is characterized by the
non-conserved Met70 and Lys285 residues (Figs. 3B and 5A),
which respectively replace an invariant Tyr residue and an
acidic residue in the long  loop (Cys67–Cys94 in BfAChE) and
at the tip of the 36,7-46,7 loop of other AChEs (Fig. 2A) and
mainly contribute to the low sensitivity of the snake enzymes to
PAS inhibitors (27, 38). Compared with TcAChE or mAChE,
the Met substitution in BfAChE slightly enlarges the gorge
entrance; however, this feature does not seem to be associated
with a greater turnover number (27) (data not shown). Inciden-
tally, BLAST searches using the BfAChE sequence as a template
identified close orthologs sharing 86 –94% sequence identity
along with the two PAS mutations in the genome of the snakes
5 C. Weise, X. Cousin, and C. Bon, personal communication.
FIGURE 1. Functional and electrophoretic characterization of BfAChE and
its Elec410 and Fab410 complexes. A, SDS-PAGE of BfAChE (non-reducing
conditions; 12.5% PhastGel). The molecular weight markers are displayed and
labeled. B, comparative isoelectric focusing analysis of mAChE (lane 1) and
BfAChE (lane 2) (pI 4.0 – 6.5 PhastGel). The pI limits of the gel are indicated.
BfAChE is as heterogeneous in charge as mAChE, but it displays higher overall
pI value. C, native PAGE (7.5% PhastGel) of BfAChE (lane 1), Fab410 (lane 2),
and pre-incubated Fab410/BfAChE mixtures in a 0.75:1, 0.9:1, 1:1, and 1.2:1
molar ratio (lanes 3– 6) with migration from the cathode (top) toward the
anode (bottom). The cationic character of Fab410 is evident. Both BfAChE
and Fab410 are homogenous in mass but not in charge, due to heteroge-
neous N-glycosylation of natural BfAChE (38, 67) and nonspecific C-termi-
nal processing of Fab410 by papain (32); however, all isoforms form com-
plexes as assessed by the inhibition curves (D; below) and further verified
by analytical gel filtration (not shown). D, inhibition of BfAChE by Elec410
and Fab410 at equilibrium (individual experiments). Data points corre-
spond to the average  variation of duplicates. Non-linear fitting used a
sigmoidal equation. The slight difference in the IgG (squares) and Fab
(circles) affinities for BfAChE may reflect their relative avidity. The signifi-
cant residual (fractional) activity of BfAChE at near saturating concentra-
tions of Elec410 or Fab410 is evident. Mean IC50 and residual activity val-
ues from three to four independent experiments are reported in Table 1 as
are those for the inhibition of EeAChE.
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Suta fasciata, Echiopsis curta, and Denisonia devisi, suggesting
evolutionary relationships.
At the PAS, bound Fab410, which displays the canonical
-sandwich Ig fold, is trapped between the glycan chains linked
to Asn343 and Asn453 on each side of the gorge entrance (see
below) with its long axis tilted by 30° from the main axis of the
gorge (Figs. 3A, 4A, and 5A). At the interface between the VH
and VL domains, the pocket-shaped combining site, 12 Å long
FIGURE 2. Sequences of the AChE species mentioned in this study and of Fab410. A, the sequences of BfAChE from snake venom, TcAChE and EeAChE from
electric fishes, and mAChE from mouse are displayed (38, 45, 78, 79). The residue numbering and secondary structure elements displayed above the alignment
are those of BfAChE. Conserved residues are shown on a black background, and non-conserved residues are shown on a white background. The symbols above
the alignment point to BfAChE-specific PAS residues Met70 and Lys285 (squares) and to EeAChE residues whose substitution by rat AChE residues abolished
(S75L for BfAChE Ser74) or reduced (L282H for BfAChE Ser280) Elec410 binding (45) (vertical bars). The symbols below the alignment point to the conserved
catalytic triad residues (stars), to BfAChE residues buried at the Fab410 complex interface (triangles), and to BfAChE Asn residues within consensus N-glyco-
sylation sequences (38) (closed circles). The arrow at the BfAChE C terminus denotes the end of the mature protein (38). B, sequences of the Fab410 L (top) and
H (bottom) chains showing the CDR positions (shaded) and secondary structure elements. Fab410 residues buried at the BfAChE complex interface are
indicated by triangles. In the structure, a Trp was found at position 200 of the H chain instead of an Arg as published previously (32). For an alignment of Fab410
with Fab403 and Fab408, see Fig. 1 in Bourne et al. (32).
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and 5 Å wide, is delimitated by the protruding CDRs H2 and
H3 and the emerging although shorter CDRs H1 and L3 (Fig.
2B). The paratope surface is markedly electropositive and con-
fers a clear anisotropic distribution of charges on the Fab410
variable domains (Fig. 3B) with a dipole moment of 780 debyes
that points toward the H chain and emerges near Lys67 in the
VH domain (not shown). This feature is consistent with the
calculated high pI value (8.1) of Fab410 and its retention close
to the cathode in native PAGE (32) (see Fig. 1C, lane 2). It is also
consistent with interaction of Fab410 with the PAS of BfAChE
competitively with the cationic ligands Fas2 and propidium and
bisquaternary ligands edrophonium and decamethonium (27).
Compared with the theoretical model of unbound Fab410 (32),
the experimental structure of bound Fab410 displays overall
good overlap (see the root mean square deviation value under
“Experimental procedures”) except for the flexible tip of the
long CDR H3, whose inverted curvature better accommodates
the long  loop at the BfAChE surface.
Evidence for Coexisting Open and Closed States of a Back
Door Channel in All BfAChE Subunits—At the bottom of the
BfAChE active site, the phenol ring of Tyr442, which is located
in loop 8-18,9 in the back door region (Fig. 2A), adopts two
alternate conformations equally represented in each BfAChE
subunit (Fig. 4). In one conformation, the hydroxyl group of
Tyr442 is tightly bound to the indole nitrogen atoms of Trp84
and Trp442 and to the carbonyl of Gly80 as observed in most
AChE structures. In the second conformation, the Tyr442 phe-
nol ring is rotated by 110° and points toward the subunit
surface, to occupy a hydrophobic pocket lined with Phe423,
Leu430, Val438, and Phe446, where the hydroxyl establishes weak
interactions with Ala427 in the 8-18,9 (Ala427–Gly437) surface
loop associated with an outward displacement (up to 2 Å) at the
loop tip (Fig. 4, A and B). The large rotational gating motion of
the Tyr442 phenol ring opens a narrow channel, 15 Å long and
3– 4 Å wide (i.e. a radius of approximately one-half that of the
constricted region located midway in the active site gorge),
roughly perpendicular to the main axis of the gorge path (Fig. 4,
C and D). The channel begins at the anionic subsite within the
active site pocket, and then it curves around the edge of Trp84 to
insert deeper between the 3,2 and 18,9 helices, exemplified
by Met83 and Glu445, respectively, to finally emerge as a surface
dimple lined by side chains from the Ala427–Tyr442 and Leu456–
Tyr458 loops in the back door region.
Most of the residues that line this channel (e.g. Met83, Trp84,
Trp432, and Glu445) are conserved in most AChE species (Fig.
2A), suggesting that channel opening is a constitutive func-
tional event. In fact, in the aflatoxin-bound TcAChE dimer, a
similarly rotated Tyr442 phenol ring associated with an open
channel is observed in one subunit, whereas the usual Tyr442
TABLE 2





Cell parameters (Å) a  156.59, b  251.34, c  73.98




Completeness (%) 99.9 (99.4)
((I)/(I)) 10.2 (2.0)
Rsymc 10.5 (59.4)
B Wilson (Å2) 64.1
Refinementd
R-factor /Rfree (%) 20.2 (22.8)/24.1 (29.2)
r.m.s.d.e
Bonds (Å)/angles (°) 0.01/1.25





Residues in favored/outlier regions (%) 96.9/0.2
PDB accession code 4QWW
a Values in parentheses are those for the highest resolution shell.
b European Synchrotron Radiation Facility.
c Rsym  	hkl(	iIhkl  
Ihkl)/	hkl
Ihkl.
d R-factor  	hklFo  Fc/	hklFo. Rfree is calculated for 2% of randomly selected
reflections excluded from refinement.
e Root mean square deviations from ideal geometry.
f Ramachandran plot statistics have been calculated with the MolProbity server.
FIGURE 3. Overall structure of the Fab410-BfAChE complex and electro-
static properties of the binding surfaces. A, two BfAChE subunits related by
a 2-fold symmetry axis and linked through a tightly packed four-helix bundle
made of their 37,8 and 10 helices assemble as a non-covalent antiparallel
dimer. Two Fab410 molecules are bound on opposite faces of the dimer with
their CDRs tightly apposed to the PAS regions. The BfAChE subunits are dis-
played in yellow with labeled N and C termini, a green four-helix bundle at the
dimer interface, a brown long  loop at the complex interface, red catalytic
residues at the center of the subunits, and orange N-glycan moieties linked to
Asn343 and Asn453 (labeled). The Fab410 L and H chains and their molecular
surfaces are displayed in dark blue and wheat, respectively. CDRs L1, L2, and L3
are displayed in blue, light green, and dark green, and CDRs H1, H2, and H3 are
displayed in red, orange, and purple, respectively, with a clearly visible
extended CDR H2 (see also Figs. 4A and 5A, right panel). B, distribution of the
electrostatic potentials mapped onto the molecular surfaces of BfAChE (left)
and Fab410 (right) at 3kT/e (red) to 3kT/e (blue) (molecules not on scale).
The charge complementarity of the electronegative binding surface on
BfAChE, which is centered on the gorge entrance (white arrow), versus the
electropositive combining site in Fab410, which is centered on the H chain
CDRs, is evident. The N and C termini of the BfAChE subunit, key residues
Met70 and Lys285, and the N-glycosylated Asn453 and Asn343 are labeled.
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conformation with no channel is retained in the second subunit
(26) (Fig. 4, C and D). In unliganded DmAChE, a genuine back
door channel exists due to Ile and Asp substitutions to Met83
and the bulky Tyr442, respectively, that destabilize Trp84 (25)
(Fig. 4C). However, in both Fab410-bound BfAChE and aflatox-
in-bound TcAChE (but not apo-DmAChE), the channel dis-
plays a significant bottleneck, dictated by the orientation of the
facing Trp84 and Trp432 side chains and narrower than the con-
stricted region in the active site gorge (Fig. 4, C and D). Hence,
even with a high Tyr442 rotation frequency as denoted in the
two structures, additional conformational changes leading to
substantial bottleneck enlargement in these liganded AChEs
would be required to permit substantial trafficking of molecules
through the back door channel. In this context, species-depen-
dent substitutions (Pro434 in BfAChE versus Glu434 in TcAChE)
in the 8-18,9 loop region bearing Tyr442 may cause local con-
FIGURE 4. The back door region in Fab410-bound BfAChE and comparison with other AChEs. A, overall view of the Fab410-BfAChE complex (one subunit
only) slightly rotated from Fig. 3A (top subunit) to better show the solvent-accessible paths in BfAChE. The lining walls of the active site gorge and back door
channel are shown as transparent green and red surfaces, and their pathways are shown as green and red center lines, respectively (other color codes are as in Fig.
3A). B, omit electron density maps contoured at 3.0 of the back door region in BfAChE showing the two equally represented alternate conformations of Tyr442
and their respective interactions with neighboring residues stabilized by H-bonds (dashed lines). C, close-up views of the continued path from the PAS at the
gorge entrance to the back door region in BfAChE (left), TcAChE (center) (PDB code 2XI4) and DmAChE (right) (PDB code 1DX4) in the same orientation with
green and red lining walls for the active site gorge and back door channel (see A). BfAChE and TcAChE Tyr442 in the rotated conformation and DmAChE Asp482
are displayed in pink, whereas BfAChE and TcAChE Tyr442 in the usual conformation are in white. Key side chains from the long  loop are in brown, and those
lining the channel are in yellow for BfAChE, light orange for TcAChE, and green for DmAChE. In BfAChE and TcAChE, Tyr442 in the rotated conformation points
toward a neighboring hydrophobic pocket and leaves the back door channel open, whereas in DmAChE, Asp482 is too small to occlude the channel. D, profiles
of the back door channel in BfAChE (red line), TcAChE (orange line), and DmAChE (brown line) and of the gorge path in BfAChE up the constricted region midway
in the gorge (green line) as calculated by CAVER. (The dotted line denotes the gorge path between the constricted region and the gorge entrance that was
ignored by the program.)
Structure of the Fab410-BfAChE Complex
























formational rearrangements and dynamic enlargement of the
back door channel. These observations, along with the fact that
none of these three AChEs display particularly high catalytic
activity compared with the average activity of most AChEs,
would support the previously proposed absence of functional
relevance of a back door in apo-AChE (24, 69) in contrast with
the role of gated tunnels to regulate other enzymes or ion chan-
nels (70).
Compared with the various Fas2-AChE complexes, which
show tightly bound Fas2 at the PAS with a fully occluded gorge
entrance and no back door channel in the crystal state (14, 23,
71–74) and display residual activities not exceeding a few per-
cent in solution (15, 75–77), the semi-occluding Fab410 posi-
tion at the BfAChE PAS and presumed higher opening fre-
quency of the back door channel in the complex are likely to
account for the greater residual activity of the Fab410-BfAChE
complex (Table 1). However, the presence of bound Fab410 at
the BfAChE PAS raises a question as to whether both confor-
mations of Tyr442 preexist in unliganded BfAChE or whether
one of them is correlated with (i.e. associated with or induced
by) Fab410 binding and, if so, which one is the apo conforma-
tion. In fact, close proximity of residues at the tip of CDR L1 in
Fab410 to residues in helix 3,2 of BfAChE, e.g. Gln79 (Glu in
mAChE and Ser in TcAChE) that lines the exit of the back door
channel, suggests that bound Fab410 could interfere with the
trafficking of small molecules through the channel. In the
absence of a structure of unliganded BfAChE, close examina-
tion of the complex interface and structural comparison with
other AChEs in the unliganded form (below) are a suitable way
to explore this hypothesis. Whether this alternative route is
efficiently used during AChE catalysis for substrate/product
trafficking and how channel opening is regulated remain to be
investigated, in focusing on the dynamic aspects of the enzyme
during ligand binding.
The Fab410-BfAChE Complex Interface and Implications of
the Structure for BfAChE Inhibition by Fab410 —At the com-
plex interface, the concave combining site of Fab410 sequesters
the tip of the long  loop located on one side of the gorge rim
(Figs. 3 and 4A). As a result, the  loop tip, whose conformation
is already constrained by Pro76, is further rigidified within the
Fab410 combining site. In fact, comparison of the Fab410-
bound BfAChE and apo-mAChE structures points to a slightly
more open (by as much as 2 Å) Ser74–Gln79 segment at the loop
tip, suggesting the occurrence of a rigid body movement upon
Fab410 binding.
An average surface area of 900 Å2 is buried on each partner
of the complex with the Fab410 H and L chains contributing
500 and 400 Å2, respectively, and the binding interface is
FIGURE 5. The Fab410-BfAChE complex interface. A, overall views of the buried interfaces at the molecular surfaces of BfAChE (left) (same color codes as in
Figs. 3A and 4A) and Fab410 (center) (yellow buried surface overlaid onto the CDRs colored as in Figs. 3A and 4A and in the right panel) in the complex (molecules
oriented 90° from each other; not drawn on scale). The positions for Met70 and Lys285, which distinguish the PAS of BfAChE from those of other AChEs, are
shown in violet; that for Trp279 (Trp279/280/286 in TcAChE/EeAChE/mAChE) is in light blue; those for Ser74 and Ser280, corresponding to EeAChE Ser75 and Leu282
whose substitution by rat AChE residues alters Fab410 binding, are in green; and that for Asn343, corresponding to EeAChE Asn345 whose deglycosylation
enhances Fab410 binding, is in pink. Right, the Fab410 combining surface with only the colored CDRs. B, close-up views of the Fab410-BfAChE complex
interface with (left) and without (right) the molecular surface of BfAChE showing the key BfAChE residues (italicized labels; encircled Ser74) and Fab410 CDR
residues (same orientation and color codes as in A with red oxygen and blue nitrogen atoms). The arrows point to the BfAChE active site gorge entrance.
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dominated by electrostatic interactions (Fig. 5 and Table 3). In
BfAChE, 12 residues of the long  loop segment Tyr68–Met90
contribute 70% of the binding interface, whereas neighboring
Asp342 in the 17,8-27,8 loop and Gln272 and Asp276 in the
facing helix 36,7 across the gorge entrance provide additional
contact points at the interface periphery. The Asn343-linked
glycan chain contributes an additional interface area of 350
Å2, thereby providing additional stability to bound Fab410.
In Fab410, the central position of the H chain places the
strongly electropositive CDR H2 (32) close to the gorge
entrance with the side chains of Arg52, Asn56, and Lys57 point-
ing within the gorge (Fig. 5 and Table 3). The tip of the extended
CDR H3, which encompasses the aromatic Tyr104/Tyr105/
Tyr109 triplet, comfortably anchors Fab410 at the PAS periph-
ery where it contributes 55% of the area buried by the H chain.
In contrast, CDR H1 only weakly contributes to the interface as
only Thr31 at its tip interacts with Asp276 in helix 36,7 of
BfAChE. Unexpectedly, BfAChE Met70 and Lys285, which are
located at the base of the long  loop and in the 36,7-46,7
loop, respectively, and which distinguish the PAS of BfAChE
and NnAChE from other AChE species, weakly contribute to
Fab410 binding as only Met70 establishes long range van der
Waals contacts with Ser55 at the tip of CDR H2. In more detail,
the non-CDR residue Arg50 interacts with BfAChE Ser75 in the
long  loop, whereas Ser55 at the tip of CDR H2 is bound to
Asp276 (Ala in NoAChE) across the gorge entrance. In CDH H3,
Tyr104, which adopts two alternate conformations related by a
45° arc motion, abuts on the external face of the long  loop
where it interacts with the Pro86 carbonyl and the Met90 side
chain; Tyr105 extends the network of interactions with BfAChE
Tyr68 and Met90 in the long  loop and with Gln272 in helix
36,7; and Tyr109 is bound to BfAChE Glu82 and in van der
Waals contact with Thr73 and Pro76 all in the long  loop.
For its part, the Fab410 L chain is positioned near the tip of
the long  loop in BfAChE, away from the gorge entrance, with
CDR L3 contributing most of the binding interface (Fig. 5 and
Table 3). In the Naja AChEs, substitution of the Asp276-Glu277
pair in helix 36,7 by an Ala-Lys pair5 may confer electrostatic
repulsion with the positively charged CDR H2 and be respon-
sible for the weak inhibition by Elec410 (27). In more detail, the
Ser30-Tyr31 pair at the CDR L1 tip on the interior face of the Fab
molecule interacts with BfAChE Gln79. In CDR L2, only the
Arg49 guanidinium, in stacking interaction with CDR L1 resi-
due Tyr31, interacts with the BfAChE Pro76 carbonyl and the
Glu82 carboxylate. In CDR L3, Tyr90, which is located at the L
chain/H chain interface, establishes stacking interactions with
BfAChE Pro76; Asn91 interacts with BfAChE Phe78; Ser92 inter-
acts with BfAChE Lys341 and Asp342 in the 17,8-27,8 loop,
which is remote from the gorge entrance; and His93, which is in
contact with H chain residues Arg50 and His61, interacts with
BfAChE Tyr75.
In contrast to bound Fas2 that occludes the AChE gorge
entrance in crystalline complexes (see above), bound Fab410
only partially occludes it so that the PAS region near loop
Tyr334–Gly335, which faces the long  loop across the gorge
rim, remains solvent-accessible (Fig. 6A). Moreover, Fab410
lacks an equivalent to Fas2 Met33, which protrudes at the tip of
loop II to interact with Trp279 and act as a central plug. Hence,
both these features and the open back door are likely to account
for the greater residual activity of the Fab410 complex com-
pared with Fas2 complexes (Table 1 and see above). However,
the nature and spatial arrangement of key positively charged or
aromatic side chains from other Fas2 loops and Fab410 CDRs
surrounding the gorge rim are remarkably conserved despite
the very moderate overlap of their backbone traces, an obser-
vation consistent with the cationic nature of both ligands (Fig.
6A). Indeed, compared with the Fas2-mAChE complex (14),
CDR H2 residue Lys57 mimics Fas2 Arg27 near the gorge
entrance, and CDR H2 Arg52 and Lys54 correspond to Fas2
Arg24 and Lys25, respectively; the neighboring Fab410 Arg50
coincides with Fas2 Arg37; and CDR L3 Tyr90 and CDR L2
Arg49, respectively, coincide with Fas2 Tyr4 and Arg11 at the
gorge periphery, thereby providing still another example of
exquisite mimicry of the molecular determinants of organic
and peptidic PAS ligands (18).
Implications of the Structure for EeAChE Inhibition by
Fab410 —All three Elec antibodies were raised against EeAChE,
and Elec403, Elec408 and their Fab derivatives inhibit EeAChE
only. In contrast, Elec410 and Fab410 inhibit both EeAChE and
BfAChE although with distinctive dissociation constant and
residual activity values (Table 1), suggesting slightly different
Fab410 positioning and/or interaction networks at the respec-
tive gorge entrances. In fact, six non-conservative substitutions
are found in the PAS regions of these two AChEs of which three
(Tyr71, Ser80, and Ser287 in EeAChE in place of Met70, Gln79,
and Lys285 in BfAChE) are located within the Fab410 binding
site at the BfAChE surface (see Fig. 2A). To explore the possible
mode of Fab410 binding onto EeAChE, we performed a soft-
ware-assisted docking of the crystalline Fab410 molecule onto
the PAS of a modeled EeAChE subunit and validated this pro-
cedure by redocking Fab410 onto the PAS of BfAChE using the
same parameters (see “Experimental Procedures”).
The modeled Fab410-EeAChE complex (Fig. 6B) shows a
similarly bound and oriented Fab410 on one side of the gorge
rim of EeAChE as observed for BfAChE, consistent with the
TABLE 3
Electrostatic interactions at the BfAChE-Fab410 complex interface
BfAChE residues not conserved in other AChEs are italicized. The corresponding
EeAChE residues are indicated in parentheses.
BfAChE Fab410
Residue Atom Residue Atom CDR
Asp72 O Tyr109 O	 H3
Thr73 O
1 Arg52 N	1 H2
O
1 Asn56 N2 H2
Ser74 (Ser75) O Arg50a N	1 (H)
Tyr75 O	 His93 N1 L3
Pro76 O Arg49 N	2 L2
O Tyr33a O	 (L)
Gly77 O Tyr31 N L1
Gln79 (Ser80) O1 Tyr31 O	 L1
N Ser30 O
 L1
Glu82 O1 Tyr104 O	 H3
O1 Arg49 N	2 L2
O2 Tyr109 O	 H3
Pro86 O Tyr104 O	 H3
Gln272 O1 Tyr105 O	 H3
Asp276 O Ser55 O
 H2
Lys341 N Asn91 O L3
N Ser92 O
 L3
Asp342 O2 His93 N1 L3
a Fab410 residues not in a CDR.
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weak contribution of BfAChE Met70 and Lys285, which are
replaced by Tyr71 and Ser287 in EeAChE, to Fab410 binding
(Figs. 2A and 6B). The model also highlights those three substi-
tutions in the PAS of EeAChE that are likely to contribute to the
greater affinity for Fab410 (Table 1). First, the phenol ring of
EeAChE Tyr71, which replaces BfAChE Met70, is well posi-
tioned on the solvent-exposed face of the long  loop to estab-
lish polar interactions with Arg52 and Asn56 in CDR H2. Sec-
ond, the polar side chain of neighboring EeAChE Ser80, which is
smaller than the corresponding BfAChE Gln79, is better suited
to closely accommodate the tip of CDR L1. Third, EeAChE
Ser287 in place of BfAChE Lys285 in the short  loop presents
suitable electrostatic complementarity with the facing Lys54 in
CDR H2. In turn, EeAChE Ser75 at the tip of the long  loop and
conserved in BfAChE abuts on Arg50 and Arg52 in CDR H2, a
position consistent with its critical contribution to Fab410
binding, as shown by loss of inhibition upon substitution of this
small polar side chain by the Leu side chain found in mamma-
lian AChEs (45). As well, the absence of Fab410 interaction with
EeAChE Leu282, which corresponds to BfAChE Ser280, reflects
the limited reduction in Fab410 affinity observed upon substi-
tution of this residue by the mammalian His counterpart (45).
Hence, this experimentally based model of the Fab410-EeAChE
complex largely accounts for the greater affinity of EeAChE for
Fab410 and the absence of Elec410 effect on human, bovine,
Torpedo, and Naja AChEs (27, 31) and mAChE (data not
shown).
Of the three N-glycosylation sites located near the BfAChE
gorge entrance, those at Asn343 (occupied in the structure) and
Asn457 (non-occupied) correspond to EeAChE Asn345 and Asn488,
whereas the third site at Asn453 (occupied) corresponds to
EeAChE Glu484 (Fig. 2A). Whether EeAChE Asn345 and Asn488
are both occupied is unknown, but at least one is because deglyco-
sylation of EeAChE results in 10-fold greater sensitivity to inhi-
bition by Fab403, despite unaltered inhibition by Fab410 (32).
Hence, distinctive distribution and/or nature of the glycan chains
in the PAS regions of EeAChE and BfAChE may provide distinc-
tive constraints onto Fab410 positioning and contribute to the
80-fold difference in the affinities of the two enzymes (Table 1).
Finally, this predicted mode of Fab410 binding at the
EeAChE PAS is also consistent with its competition with the
large peptidic inhibitor Fas2 but absence of competition with
the small organic inhibitors propidium, decamethonium,
BW284C51, and the substrate acetylcholine when in excess
(31). In fact, structural comparison of the crystalline Fab410-
BfAChE and modeled Fab410-EeAChE complexes with crys-
talline mAChE or TcAChE complexes with acetylcholine (8,
9) and propidium (18) and with the bifunctional ligands
BW284C51 (63) and decamethonium (62) points to only one
critical steric clash occurring between the propidium alkyl
chain and Lys57 in Fab410 CDR H2 (data not shown). This
observation along with the greater improvement of propidium
binding observed for the M70Y mutant of BfAChE compared
with its K285D mutant (38) also largely supports our model of
the Fab410-EeAChE complex.
In summary, this biochemical and structural analysis of the
Fab410-BfAChE complex illustrates the capacity of the snake
venom enzyme to form canonical dimers of subunits despite its
FIGURE 6. Comparison of the Fab410-BfAChE complex with other peptidic inhibitor-AChE complexes. A, overall views of the crystalline Fas2-mAChE
complex (left) (PDB code 1KU6) and the 1029-Å2 buried interface at the mAChE surface in this complex (center) (left and right mAChE molecules are oriented 90°
from each other). Fas2 is displayed in light green, and mAChE Trp286 is in light blue (other color codes as in Fig. 3A). Right, spatial alignment of the key interacting
aromatic and positively charged side chains in BfAChE-bound Fab410 (plain labels; color codes as in Fig. 5) and mAChE-bound Fas2 (italicized labels; green side
chains) overlaid onto the Fas2 backbone (light green ribbon). Their similar positioning along with the absence of a Fab410 residue mimicking Fas2 Met33 in its
interaction with Trp279 (displayed in light blue on the right) is evident. B, overall views of the theoretical model of the Fab410-EeAChE complex (left) and the
1017-Å2 buried interface at the EeAChE surface in this complex (right) (left and right EeAChE molecules are oriented 90° from each other). In the right panel, the
buried EeAChE surface is colored according to the L chain and H chain CDRs in bound Fab410 (see Fig. 5A), and EeAChE Ser75, Leu282, and Asn345 are color-coded
as in Fig. 5.
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unusual, non-amphiphilic C terminus; documents the mode of
binding of one of the largest peptidic inhibitors targeting the
PAS of an AChE; and reveals the molecular determinants asso-
ciated with inhibition of BfAChE and EeAChE, but not other
AChEs, by this antibody. Most particularly, our data provide a
precise picture of the antibody pose on one side of the active site
gorge entrance and unveil an equilibrium of closed and open
states of a back door channel not observed in previous AChE
structures, two features likely to be correlated with the signifi-
cant residual activity of this particular complex. Hence, this
study provides a novel AChE template to explore alternative
binding perimeters and topographies at the PAS surface for
non-competitive modulators of catalysis along with new deter-
minants and mechanisms associated with the dynamics of back
door opening. The availability of crystal structures of AChE
complexes with Fab403 and Fab408, which target the PAS and
back door region, respectively, would complete the picturing of
the molecular determinants and mechanisms involved in regu-
lation of AChE catalysis by the “Elec” mAbs.
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